Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.950
+0.060 (3.17%)
Nov 28, 2025, 4:00 PM EST - Market closed
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
$81,987
Profits / Employee
-$298,797
Market Cap
182.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | 215 | -29 | -11.89% |
| Dec 31, 2020 | 244 | 9 | 3.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IPHA News
- 15 hours ago - Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025 - Business Wire
- 11 days ago - Innate Pharma to Present at Jefferies Global Healthcare Conference - Business Wire
- 14 days ago - Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results - Business Wire
- 18 days ago - Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL - Business Wire
- 23 days ago - Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates - Business Wire
- 4 weeks ago - Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript - Seeking Alpha
- 6 weeks ago - Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025 - Business Wire